I-hung Shih's Email & Phone - Temasek

I-hung Shih's Work Experience

Temasek

Associate Director

September 2014 to Present

Greater New York City Area

Credit Suisse

Associate

July 2011 to August 2014

Gilead Sciences, Inc

Senior Manager

2009 to April 2011

I-hung Shih's Education

University of Pennsylvania - The Wharton School

MBA Wharton WEMBA

2009 to 2011

Massachusetts Institute of Technology

Postdoctoral Molecular and cellular Biology

2002 to 2005

Duke University

PhD Biochemistry

1995 to 2000

I-hung Shih's Professional Skills Radar Chart

Based on our findings, I-hung Shih is ...

Confident

Structured

Self-critical

What's on I-hung Shih's mind?

Based on our findings, I-hung Shih is ...

56% Left Brained

44% Right Brained

I-hung Shih's Estimated Salary Range

About I-hung Shih's Current Company

Temasek

Investment management focused on biopharmaceutical sector

Frequently Asked Questions about I-hung Shih

What company does I-hung Shih work for?

I-hung Shih works for Temasek

What is I-hung Shih's role at Temasek?

I-hung Shih is Associate Director

What is I-hung Shih's personal email address?

I-hung Shih's personal email address is i****[email protected]

What is I-hung Shih's business email address?

I-hung Shih's business email addresses are not available

What is I-hung Shih's Phone Number?

I-hung Shih's phone (301) ***-*231

Who are I-hung Shih's colleagues?

I-hung Shih's colleagues are Jennifer Young, Patti Norman, Davin Tryon, Justin Durham, Stephen Castro, John Palmen, Becca Willey, Shawn Mcconnon, Michael Grunseth, and Andrew Winder

About I-hung Shih

📖 Summary

Investment Banking Commercial Strategy Drug Discovery Biopharmaceutical BiotechnologyAssociate Director @ Investment management focused on biopharmaceutical sector From September 2014 to Present (1 year 4 months) Greater New York City AreaAssociate @ Investment banking specialized in merger and acquisition, equity and debt financing for Biotech industry - Advised healthcare companies on acquisitions, partnership, capital raises, divestitures, and shareholder-related matters - Led due diligence, develop/analyze financial models, draft marketing documents, and execute transactions - Executed 30+ deals totaling more than $20 billion across buy-side/sell-side advisory, equity and debt offering From July 2011 to August 2014 (3 years 2 months) Senior Manager @ Commercial Strategy, Antiviral/Hepatology Franchise - Advised senior management on commercial assessment, including sales forecasting, market research, and competitive analysis, to drive strategic decisions on developing cardiovascular therapeutics - Established and maintained portfolio valuation of internal programs in HCV area by scenario and competitive analysis - Assessed acquisition opportunities based on DCF valuation aligned with internal strategic interest - Evaluated early-stage licensing opportunities of antiviral therapeutics by market opportunities and technical assessment From 2009 to April 2011 (2 years) Research Scientist II @ - Led drug discovery team for identifying early HCV therapeutics - Characterized MOA of two clinical development compounds - Characterized MOA of clinical candidates - Prepared FDA documents for clinical candidates - Coordinated business development evaluation-biology - Alliance management of external collaborations. From 2007 to 2009 (2 years) Research Scientist I @ -Coordinated biology output for 3 drug discovery project team -Business development evaluation-Biology/HCV -Led a group of 3 biologists From 2005 to 2006 (1 year) Research Fellow @ Investigate functions of microRNAs in adipogenesis as joint fellow in Bartel and Lodish's labs. From 2002 to 2005 (3 years) Research Fellow @ Investigate roles of enzymes RAG1 and RAG2 in chromocosomal translocation. From 2000 to 2002 (2 years) MBA, Wharton WEMBA @ University of Pennsylvania - The Wharton School From 2009 to 2011 Postdoctoral, Molecular and cellular Biology @ Massachusetts Institute of Technology From 2002 to 2005 PhD, Biochemistry @ Duke University From 1995 to 2000 BS, Chemistry @ National Taiwan University From 1991 to 1995 I-hung Shih is skilled in: Biotechnology, Drug Discovery, Lifesciences, Clinical Development, Molecular Biology, Biochemistry, Investment Banking, Corporate Finance, M&A experience, Drug Development, Virology, Infectious Diseases, Oncology, IPO, Hepatology, Assay Development, Debt & Equity Financing

I-hung Shih’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.